When antibiotics fail: Solving the deadly superbug threat

Antibiotics save millions of lives — but what happens if they stop working? The WHO calls antimicrobial drug resistance, or AMR, one of the largest threats to global health and food security; it kills more people annually than HIV/AIDS or malaria. Without intervention, we risk returning to a pre-antibiotic era where common infections are deadly. This panel discussion will explore ways to reduce antibiotic resistance through stewardship, innovation, and regulation. We’ll also examine the fragile antibiotic pipeline and examine ways to encourage development of new therapies.  

Register for free to submit your questions.   

An on-demand video will be posted after the event. 

PANELISTS

Henry Skinner, CEO of the AMR Action Fund 

Yewande Alimi, Antimicrobial Resistance (AMR) Program Coordinator, Africa Centres for Disease Control and Prevention & co-lead for the Africa Union Task force on AMR 

Akhila Kosaraju, CEO and President, Phare Bio 

MODERATOR

Sarah Fortune, John LaPorte Given Professor of Immunology and Infectious Diseases; Chair, Department of Immunology and Infectious Diseases, Harvard T.H. Chan School